Toby Wegman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Toby Wegman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Toby Wegman. Toby Wegman is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and President in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE).
Latest Insider Trading Transactions of Toby Wegman
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 17 2020 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Grant | A | 0.00 | 1,726 | 0 | 3,616 | 1.9 K to 3.6 K (+91.32 %) |
Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.16 | 8,900 | 490,924 | 935,073 | 944 K to 935.1 K (-0.94 %) |
Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.16 | 8,900 | 490,924 | 935,073 | 944 K to 935.1 K (-0.94 %) |
Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.23 | 1,100 | 60,753 | 943,973 | 945.1 K to 944 K (-0.12 %) |
Sep 10 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 55.23 | 1,100 | 60,753 | 943,973 | 945.1 K to 944 K (-0.12 %) |
Jul 02 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Grant | A | 0.00 | 1,890 | 0 | 1,890 | 0 to 1.9 K |
May 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 64.67 | 100 | 6,467 | 945,073 | 945.2 K to 945.1 K (-0.01 %) |
May 22 2019 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 64.05 | 5,400 | 345,887 | 945,173 | 950.6 K to 945.2 K (-0.57 %) |
Aug 17 2018 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 51.89 | 2,500 | 129,728 | 947,473 | 950 K to 947.5 K (-0.26 %) |
Nov 29 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 48.08 | 10,000 | 480,832 | 949,973 | 960 K to 950 K (-1.04 %) |
Sep 16 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 41.21 | 3,100 | 127,751 | 959,973 | 963.1 K to 960 K (-0.32 %) |
Sep 13 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 37.55 | 3,605 | 135,350 | 963,073 | 966.7 K to 963.1 K (-0.37 %) |
Sep 02 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.50 | 1,266 | 47,475 | 966,678 | 967.9 K to 966.7 K (-0.13 %) |
Sep 02 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.53 | 7,935 | 297,824 | 967,944 | 975.9 K to 967.9 K (-0.81 %) |
Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.50 | 2,692 | 100,957 | 975,879 | 978.6 K to 975.9 K (-0.28 %) |
Aug 30 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | President | Sell | S | 37.61 | 1,607 | 60,440 | 978,571 | 980.2 K to 978.6 K (-0.16 %) |
May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 33.00 | 24,750 | 816,750 | 980,178 | 1 M to 980.2 K (-2.46 %) |
May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 34.11 | 50 | 1,706 | 1,004,928 | 1 M to 1 M (0.00 %) |
May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 34.14 | 150 | 5,121 | 1,004,978 | 1 M to 1 M (-0.01 %) |
May 19 2016 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 33.80 | 50 | 1,690 | 1,005,128 | 1 M to 1 M (0.00 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.06 | 963 | 17,392 | 1,714 | 2.7 K to 1.7 K (-35.97 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.15 | 858 | 15,573 | 2,677 | 3.5 K to 2.7 K (-24.27 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.16 | 142 | 2,579 | 3,535 | 3.7 K to 3.5 K (-3.86 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.62 | 1,076 | 20,035 | 3,677 | 4.8 K to 3.7 K (-22.64 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.62 | 500 | 9,310 | 4,753 | 5.3 K to 4.8 K (-9.52 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.68 | 100 | 1,868 | 5,253 | 5.4 K to 5.3 K (-1.87 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.63 | 200 | 3,726 | 5,353 | 5.6 K to 5.4 K (-3.60 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.39 | 1,000 | 18,390 | 5,553 | 6.6 K to 5.6 K (-15.26 %) |
Jun 18 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.26 | 1,500 | 27,390 | 6,553 | 8.1 K to 6.6 K (-18.63 %) |
Jun 13 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 18.21 | 1,500 | 27,315 | 8,053 | 9.6 K to 8.1 K (-15.70 %) |
Jun 08 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.74 | 101 | 1,792 | 9,553 | 9.7 K to 9.6 K (-1.05 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.35 | 1,395 | 24,203 | 9,654 | 11 K to 9.7 K (-12.63 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.40 | 100 | 1,740 | 11,049 | 11.1 K to 11 K (-0.90 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 17.47 | 5 | 87 | 11,149 | 11.2 K to 11.1 K (-0.04 %) |
Jun 05 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 16.75 | 1,000 | 16,750 | 11,154 | 12.2 K to 11.2 K (-8.23 %) |
Mar 30 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | M | 4.60 | 15,000 | 69,000 | 15,000 | |
Mar 30 2012 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Buy | M | 4.60 | 15,000 | 69,000 | 15,000 | 0 to 15 K |
Sep 15 2010 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 23.50 | 150,000 | 3,525,000 | 1,005,179 | 1.2 M to 1 M (-12.99 %) |
Dec 01 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 30.00 | 100,000 | 3,000,000 | 1,155,179 | 1.3 M to 1.2 M (-7.97 %) |
Sep 17 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 24.00 | 100,000 | 2,400,000 | 1,255,179 | 1.4 M to 1.3 M (-7.38 %) |
Feb 11 2009 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 20.00 | 45,000 | 900,000 | 1,355,179 | 1.4 M to 1.4 M (-3.21 %) |
Jul 07 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | A | 17.00 | 15,000 | 255,000 | 30,000 | |
Apr 09 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 11.00 | 200,000 | 2,200,000 | 1,230,111 | 1.4 M to 1.2 M (-13.98 %) |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | D | 1.10 | 100,000 | 110,000 | 15,000 | |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | D | 1.00 | 39,000 | 39,000 | 115,000 | |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 12.00 | 100,000 | 1,200,000 | 1,224,997 | 1.3 M to 1.2 M (-7.55 %) |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 12.00 | 39,000 | 468,000 | 1,324,997 | 1.4 M to 1.3 M (-2.86 %) |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Buy | X | 1.10 | 100,000 | 110,000 | 1,363,997 | 1.3 M to 1.4 M (+7.91 %) |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Buy | X | 1.00 | 39,000 | 39,000 | 1,263,997 | 1.2 M to 1.3 M (+3.18 %) |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | S | 12.00 | 205,114 | 2,461,368 | 1,224,997 | 1.4 M to 1.2 M (-14.34 %) |
Feb 05 2008 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Sell | J | 0.00 | 618,331 | 0 | 1,430,111 | 2 M to 1.4 M (-30.19 %) |
Aug 16 2007 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | A | 1.10 | 39,000 | 42,900 | 154,000 | |
Aug 16 2007 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | A | 1.00 | 39,000 | 39,000 | 115,000 | |
Aug 16 2007 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | D | 1.10 | 100,000 | 110,000 | 15,000 | |
Aug 16 2007 | BSTCE | BIOSPECIFICS TECHN ... | Wegman Toby | Director | Option Exercise | D | 1.00 | 39,000 | 39,000 | 115,000 |
Page: 1